GO:0086013 membrane repolarization during cardiac muscle cell action potential: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0086013 describes the biological process by which ion transport across the cardiac muscle cell membrane returns the membrane potential from the positive peak of the action potential toward the negative resting potential.
• Repolarization is driven by a coordinated balance of outward potassium currents, inactivation of inward calcium and sodium currents, and the activity of ion channel complexes in the sarcolemma.
• Repolarization reserve is an important concept: the heart has redundant outward current mechanisms, and loss of this reserve predisposes to arrhythmias such as long QT syndrome.
• Dispersion of repolarization across the ventricular wall is a key substrate for reentrant arrhythmias, including ventricular tachycardia and fibrillation.
• Key genes include KCNH2, KCNQ1, SCN5A, CACNA1C, KCNE1, KCNE2, KCNJ2, and others encoding channels and accessory subunits that shape the action potential.
• CRISPR-based knockout, point-mutation, and knock-in models in cardiomyocytes enable causal testing of repolarization gene variants and drug responses.
Description
Membrane repolarization during cardiac muscle cell action potential (GO:0086013) is the biological process in which ion transport across the cardiac muscle cell plasma membrane moves the membrane potential from the positive peak of the action potential back toward the negative resting potential. This process is essential for normal cardiac electrical activity, because it determines action potential duration, refractory period, and the timing of subsequent excitation. Defects in repolarization are directly linked to life-threatening arrhythmias and sudden cardiac death. Researchers study GO:0086013 to understand how ion channels, accessory subunits, and regulatory proteins coordinate to terminate the action potential and how genetic variants alter this process. The term is also central to cardiac safety pharmacology, because many drugs unintentionally prolong repolarization and increase arrhythmia risk. In this article, we summarize the definition, mechanism, key genes, disease links, and experimental methods for studying GO:0086013, with a focus on CRISPR-based models and modern readouts.
membrane repolarization during cardiac muscle cell action potential At A Glance
| GO ID | GO:0086013 |
|---|---|
| GO term | membrane repolarization during cardiac muscle cell action potential |
| Ontology | biological_process |
| Synonym | none |
| Definition | The process in which ions are transported across a membrane such that the cardiac muscle cell plasma membrane potential changes in the direction from the positive membrane potential at the peak of the action potential towards the negative resting potential. |
| Major function | Termination of the cardiac action potential and restoration of resting membrane potential |
| Key ion currents | Outward potassium currents (IKr, IKs, IK1, Ito), inactivation of ICa,L and INa |
| Related cellular component | Sarcolemma, ion channel complexes, intercalated discs |
| Related molecular function | Voltage-gated ion channel activity, ion transmembrane transporter activity |
What Is GO:0086013?
GO:0086013 is defined as the process in which ions are transported across a membrane such that the cardiac muscle cell plasma membrane potential changes in the direction from the positive membrane potential at the peak of the action potential towards the negative resting potential. In simpler terms, it is the electrical reset of a heart muscle cell after it fires. This process depends on the coordinated opening and closing of ion channels, primarily potassium channels that carry outward current, together with inactivation of inward sodium and calcium currents. Repolarization is not a single event but a phase of the action potential (phase 3) that is shaped by multiple currents and by cell-to-cell electrical interactions.
Why Is membrane repolarization during cardiac muscle cell action potential Important in Cell Biology?
Repolarization is a fundamental determinant of cardiac excitability and rhythm. Abnormal repolarization, whether due to genetic mutations, drug effects, or structural heart disease, can prolong the QT interval, increase dispersion of repolarization, and create the substrate for reentrant arrhythmias such as torsades de pointes and ventricular fibrillation. Because repolarization reserve is finite, even subtle changes in ion channel function can have major clinical consequences. Understanding GO:0086013 is therefore critical for cardiac genetics, drug safety assessment, and the development of antiarrhythmic therapies.
• Determines action potential duration and refractory period, which control heart rate and rhythm.
• Loss of repolarization reserve is a major mechanism of drug-induced arrhythmia.
• Mutations in repolarization genes cause congenital long QT syndrome and other channelopathies.
• Dispersion of repolarization across the ventricular wall promotes reentrant arrhythmias.
• Repolarization abnormalities are common in heart failure and hypertrophy.
• Species differences in repolarization currents complicate translation of animal data to humans.
• Repolarization is a key endpoint in cardiac safety pharmacology (hERG, QT prolongation).
• Cell-to-cell electrical coupling modulates early and late repolarization.
• Genetic variants in repolarization genes can be functionally dissected using CRISPR models.
• Understanding repolarization supports development of safer and more effective antiarrhythmic drugs.
What Happens During membrane repolarization during cardiac muscle cell action potential?
Phase 2 plateau and the balance of inward and outward currents
In simple terms: During the plateau, calcium coming in is balanced by potassium going out, keeping the cell depolarized.
The cardiac action potential plateau (phase 2) is maintained by a fine balance between inward L-type calcium current (ICa,L) and outward potassium currents, particularly IKr and IKs. During this phase, the membrane potential is near 0 mV, and small changes in either inward or outward current can significantly alter the duration of the plateau. The plateau is a distinctive feature of cardiac myocytes and is essential for preventing premature re-excitation.
Inactivation of inward currents and activation of outward potassium currents
In simple terms: Calcium and sodium channels close, while potassium channels open, allowing the cell to start resetting.
Repolarization begins when inward currents, especially ICa,L and the late sodium current (INa,L), inactivate, while outward potassium currents, including IKr (KCNH2), IKs (KCNQ1/KCNE1), and Ito (KCND3), activate. The rapid delayed rectifier IKr is particularly important in humans, and its dysfunction is a common cause of long QT syndrome. The slow delayed rectifier IKs provides repolarization reserve, especially during beta-adrenergic stimulation.
Phase 3 rapid repolarization and the role of IK1
In simple terms: Potassium flows out strongly, bringing the voltage down quickly to the resting level.
As outward currents dominate, the membrane potential rapidly repolarizes (phase 3). The inward rectifier current IK1 (KCNJ2) increases at negative potentials and helps to stabilize the resting membrane potential and accelerate the final phase of repolarization. Inward rectification of IK1 is due to voltage-dependent block by intracellular magnesium and polyamines, which allows the channel to carry large outward currents only during late repolarization.
Cell-to-cell electrical interactions and repolarization dispersion
In simple terms: Heart cells are electrically coupled, so one cell's repolarization can affect its neighbors.
Cardiac myocytes are electrically coupled via gap junctions, and cell-to-cell electrical interactions modulate both early and late repolarization. Differences in action potential duration across the ventricular wall (transmural dispersion) are normal but can become arrhythmogenic when exaggerated. Electrotonic coupling tends to reduce dispersion but can also create complex repolarization patterns that predispose to reentry.
Repolarization reserve and redundancy
In simple terms: The heart has backup potassium currents, so losing one current may not always cause problems unless reserve is reduced.
Repolarization reserve refers to the redundancy of outward currents that protects against excessive action potential prolongation. When one current is reduced (e.g., by a drug or mutation), other currents can compensate, but if reserve is compromised (e.g., by heart failure or additional mutations), arrhythmias may occur. This concept is critical for understanding variable penetrance in long QT syndrome and for predicting drug-induced arrhythmia risk.
Key Genes Involved in GO:0086013 membrane repolarization during cardiac muscle cell action potential
The following genes encode ion channels, accessory subunits, and regulatory proteins that directly participate in or modulate membrane repolarization during the cardiac muscle cell action potential.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KCNH2 | Alpha subunit of the rapid delayed rectifier potassium channel (IKr); carries outward current during phase 3 | Mutations cause long QT syndrome type 2; primary target for drug safety (hERG) |
| KCNQ1 | Alpha subunit of the slow delayed rectifier potassium channel (IKs); contributes to repolarization reserve | Mutations cause long QT syndrome type 1 and short QT syndrome; modulated by beta-adrenergic signaling |
| KCNE1 | Beta subunit that assembles with KCNQ1 to form IKs; modulates channel kinetics | Mutations cause long QT syndrome type 5; important for IKs function |
| KCNE2 | Beta subunit that can modulate KCNH2 (IKr) and other channels | Mutations associated with long QT syndrome and drug sensitivity |
| SCN5A | Alpha subunit of the cardiac sodium channel; carries INa and late INa | Mutations cause long QT syndrome type 3, Brugada syndrome, and conduction disease |
| CACNA1C | Alpha subunit of the L-type calcium channel; carries ICa,L that maintains the plateau | Mutations cause Timothy syndrome and long QT syndrome type 8 |
| KCNJ2 | Alpha subunit of the inward rectifier potassium channel (IK1); stabilizes resting potential and late repolarization | Mutations cause Andersen-Tawil syndrome and short QT syndrome |
| KCND3 | Alpha subunit of the transient outward potassium channel (Ito); contributes to early repolarization | Mutations associated with Brugada syndrome and early repolarization syndrome |
| KCNJ5 | G-protein-activated inward rectifier potassium channel; contributes to atrial repolarization | Mutations linked to familial hyperaldosteronism and atrial arrhythmias |
| KCNK2 | Two-pore domain potassium channel; contributes to background outward current | Modulates action potential duration and repolarization reserve |
| FGF13 | Fibroblast growth factor homologous factor; regulates sodium channel trafficking and cardiomyocyte impulse propagation | Modulates repolarization indirectly via effects on INa and Cx43 trafficking |
| SNAP25 | SNARE protein involved in membrane trafficking of Kv1.5 channels | Regulates Kv1.5 surface expression and onset of atrial fibrillation |
| Cx43 (GJA1) | Gap junction protein mediating cell-to-cell electrical coupling | Affects repolarization dispersion and impulse propagation |
| ATP2A2 | SERCA2a calcium pump; regulates intracellular calcium and indirectly affects repolarization | Modulates calcium handling and action potential duration |
| RYR2 | Ryanodine receptor calcium release channel; influences calcium transients and repolarization | Mutations cause catecholaminergic polymorphic ventricular tachycardia |
| CALM1 | Calmodulin; regulates calcium-dependent inactivation of calcium channels | Mutations cause long QT syndrome and CPVT |
| ANK2 | Ankyrin-B; cytoskeletal adaptor that targets ion channels to specific membrane domains | Mutations cause long QT syndrome type 4 and arrhythmia |
| SNTA1 | Syntrophin alpha-1; part of dystrophin-associated complex that regulates sodium channels | Mutations associated with long QT syndrome |
How Is membrane repolarization during cardiac muscle cell action potential Regulated?
Repolarization is regulated at multiple levels. Beta-adrenergic stimulation increases IKs via PKA-mediated phosphorylation of KCNQ1/KCNE1, enhancing repolarization reserve during stress. Calcium-calmodulin-dependent protein kinase II (CaMKII) phosphorylates several ion channels and can prolong action potential duration in heart failure. Membrane trafficking of potassium channels, such as Kv1.5 via SNAP25-dependent pathways, regulates the number of channels at the surface and thus repolarization capacity. Fibroblast growth factor homologous factors (FGF13) modulate sodium channel trafficking and indirectly influence repolarization. Extracellular potassium and magnesium concentrations also affect repolarization by altering channel conductance and rectification.
membrane repolarization during cardiac muscle cell action potential and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KCNH2 | Long QT syndrome type 2; drug-induced arrhythmia | Knockout or point-mutation iPSC-derived cardiomyocytes; hERG trafficking assays |
| KCNQ1 | Long QT syndrome type 1; short QT syndrome | Knock-in of patient variants in iPSC-CMs; IKs current measurements |
| SCN5A | Long QT syndrome type 3; Brugada syndrome | Knockout and point-mutation models; INa and late INa recordings |
| KCNJ2 | Andersen-Tawil syndrome; short QT syndrome | Knockout iPSC-CMs; IK1 current and action potential duration assays |
| SNAP25 | Atrial fibrillation; Kv1.5 trafficking | Knockdown or knockout in atrial cardiomyocytes; channel trafficking assays |
Long QT syndrome and inherited arrhythmias
Long QT syndrome (LQTS) is a group of inherited disorders caused by mutations in genes encoding cardiac ion channels or accessory subunits, leading to prolonged action potential duration and increased risk of torsades de pointes and sudden cardiac death. The most common subtypes involve loss-of-function mutations in KCNH2 (LQT2) and KCNQ1 (LQT1) or gain-of-function mutations in SCN5A (LQT3). These mutations directly impair repolarization, reducing repolarization reserve and creating a substrate for arrhythmias.
Drug-induced arrhythmia and cardiac safety
Many pharmacological agents unintentionally block IKr (hERG), prolonging repolarization and causing acquired LQTS. This has led to regulatory requirements for thorough QT studies in drug development. Understanding repolarization reserve helps predict which patients are at risk, especially those with underlying heart disease or genetic variants.
Heart failure and repolarization remodeling
In heart failure, downregulation of potassium currents (e.g., Ito, IKs) and altered calcium handling prolong action potential duration and increase dispersion of repolarization, contributing to arrhythmia risk. Electrical remodeling in heart failure reduces repolarization reserve, making patients more susceptible to drug-induced arrhythmias.
Atrial fibrillation and repolarization abnormalities
Atrial fibrillation is associated with electrical remodeling that shortens atrial action potential duration and alters repolarization, promoting reentry. SNAP25-dependent trafficking of Kv1.5 channels regulates atrial repolarization, and disruption of this pathway can facilitate the onset of atrial fibrillation. Targeting repolarization mechanisms in the atria is a potential therapeutic strategy.
From membrane repolarization during cardiac muscle cell action potential-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a repolarization gene prolong action potential duration? | CRISPR knockout in iPSC-derived cardiomyocytes or animal models |
| Does a specific patient variant impair channel function? | Point-mutation knock-in in iPSC-CMs followed by patch-clamp |
| Can a fluorescent tag track channel trafficking? | Tagged knock-in of KCNH2 or KCNQ1 in cardiomyocytes |
| Does overexpression of a subunit rescue repolarization reserve? | Overexpression of KCNE1 or KCNQ1 in cardiomyocytes |
| What is the role of non-channel genes in repolarization? | Knockout of FGF13 or SNAP25 in cardiomyocytes |
| Can CRISPR screening identify modifiers of repolarization? | Pooled CRISPR library screening in iPSC-CMs with voltage-sensitive dyes |
How to Study the membrane repolarization during cardiac muscle cell action potential Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp | Ion currents and action potential duration | Functional characterization of channel variants |
| Optical mapping | Spatiotemporal repolarization patterns | Dispersion and arrhythmia mapping |
| Voltage-sensitive dyes | Membrane potential changes in cell populations | High-throughput drug screening |
| CRISPR screening | Gene effects on repolarization | Discovery of novel regulators |
| RNA-seq | Gene expression changes | Transcriptomic remodeling in disease |
| Proteomics | Protein abundance and interactions | Channel complex composition |
| Immunofluorescence | Subcellular localization of channels | Trafficking studies |
| iPSC-CM differentiation | Human cardiomyocyte model | Disease modeling and drug testing |
Patch-clamp electrophysiology
Patch-clamp recordings in isolated cardiomyocytes or heterologous cells measure individual ion currents (IKr, IKs, INa, ICa,L) and action potentials, providing direct functional readouts of repolarization. This method is the gold standard for quantifying changes in repolarization due to genetic variants or drugs.
Optical mapping and voltage-sensitive dyes
Optical mapping using voltage-sensitive dyes allows simultaneous recording of action potentials from many cells in monolayers or whole hearts, revealing dispersion of repolarization and arrhythmia dynamics. This technique is valuable for studying cell-to-cell interactions and reentrant circuits.
CRISPR screening and functional genomics
Pooled CRISPR knockout or activation screens combined with voltage-sensitive dyes or calcium indicators can identify genes that modify repolarization. Such screens are unbiased and can uncover novel regulators of action potential duration.
Transcriptomics and proteomics
RNA sequencing and proteomics can quantify expression of ion channel genes and identify changes in repolarization-related pathways in disease models. These approaches complement functional studies by revealing molecular remodeling.
How CRISPR Can Be Used to Study GO:0086013 membrane repolarization during cardiac muscle cell action potential
Knockout
CRISPR knockout of repolarization genes (e.g., KCNH2, KCNQ1, SCN5A) in iPSC-derived cardiomyocytes or animal models abolishes specific currents and prolongs action potential duration, providing causal evidence for their role in repolarization. Knockout models are also used to assess repolarization reserve and compensatory mechanisms.
Point Mutation
Introducing patient-specific point mutations (e.g., KCNH2 A561V, SCN5A ΔKPQ) via CRISPR base editing or homology-directed repair allows precise functional analysis of variants in an isogenic background. These models are essential for classifying variants of uncertain significance in LQTS genes.
Knock-in
Knock-in of fluorescent tags (e.g., GFP or HaloTag) into endogenous channel genes enables real-time tracking of channel trafficking and localization in cardiomyocytes. Knock-in of reporter genes can also be used to monitor channel expression during differentiation.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of channel subunits (e.g., KCNE1, KCNQ1) can enhance specific currents and increase repolarization reserve, serving as a rescue strategy or to study gain-of-function effects. Overexpression models help dissect the contribution of individual subunits to repolarization.
How EDITGENE Supports membrane repolarization during cardiac muscle cell action potential Research
Researchers studying membrane repolarization during cardiac muscle cell action potential-related genes often need to determine whether a candidate gene is causally involved in action potential duration, repolarization reserve, or arrhythmia susceptibility. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of repolarization genes and variants in relevant cardiac cell types.
Contact EDITGENE today to design your custom CRISPR model for membrane repolarization during cardiac muscle cell action potential research.
Frequently Asked Questions About membrane repolarization during cardiac muscle cell action potential
What is GO:0086013?
GO:0086013 is the Gene Ontology term for membrane repolarization during cardiac muscle cell action potential, the process by which ion transport returns the cardiac muscle cell membrane potential from the positive peak of the action potential toward the negative resting potential.
What genes are involved in membrane repolarization during cardiac muscle cell action potential?
Key genes include KCNH2, KCNQ1, KCNE1, KCNE2, SCN5A, CACNA1C, KCNJ2, KCND3, and others encoding ion channels and accessory subunits that carry or regulate repolarizing currents.
Why is cardiac repolarization important?
Repolarization determines action potential duration and refractory period; abnormalities can cause long QT syndrome, arrhythmias, and sudden cardiac death.
What is repolarization reserve?
Repolarization reserve is the redundancy of outward potassium currents that protects the heart against excessive action potential prolongation; loss of reserve increases arrhythmia risk.
Which ion currents drive repolarization?
Outward potassium currents, including IKr, IKs, IK1, and Ito, together with inactivation of inward calcium and sodium currents, drive repolarization.
How do mutations in KCNH2 cause long QT syndrome?
Loss-of-function mutations in KCNH2 reduce IKr current, prolonging action potential duration and increasing the risk of torsades de pointes.
Can CRISPR be used to study repolarization genes?
Yes, CRISPR knockout, point-mutation knock-in, and overexpression in iPSC-derived cardiomyocytes enable causal testing of repolarization gene variants and drug responses.
What methods measure cardiac repolarization?
Patch-clamp electrophysiology, optical mapping with voltage-sensitive dyes, and multielectrode array recordings are commonly used to measure repolarization.
What diseases are linked to abnormal repolarization?
Long QT syndrome, Brugada syndrome, short QT syndrome, atrial fibrillation, and heart failure-related arrhythmias are linked to repolarization abnormalities.
How does EDITGENE support repolarization research?
EDITGENE provides CRISPR knockout, point-mutation, knock-in, overexpression, library screening, and bioinformatics services to generate and analyze cardiac cell models for repolarization studies.
Conclusion
GO:0086013 membrane repolarization during cardiac muscle cell action potential is a central biological process in cardiac electrophysiology, integrating ion channel function, regulatory signaling, and cell-to-cell coupling. Its dysfunction underlies inherited and acquired arrhythmias, making it a key target for research and drug safety assessment. Advances in CRISPR-based models and functional genomics now allow precise dissection of repolarization mechanisms and variant effects in human cardiomyocytes. Continued investigation of this process will inform new therapies and improve risk stratification for cardiac arrhythmias.
References
- 2. Das LT et al.. 2025. FGF13 Regulates VGSC-Independent Cardiomyocyte Impulse Propagation via Cx43 Trafficking.. Circ Res 137(12):1522-1539 PMID: 41200819
- 3. Su X et al.. 2025. SNAP25-dependent membrane trafficking of the Kv1.5 channel regulates the onset of atrial fibrillation.. Nat Commun 16(1):3730 PMID: 40253375
- 4. Zaniboni M. 2024. In silico analysis of ventricular action potential with a current-voltage-time representation: Thresholds, membrane resistance, repolarization reserve.. Physiol Rep 12(21):e70085 PMID: 39529595
- 5. Spitzer KW et al.. 2006. Cell-to-cell electrical interactions during early and late repolarization.. J Cardiovasc Electrophysiol 17 Suppl 1:S8-S14 PMID: 16686687
- 6. Wallace E et al.. 2019. Long QT Syndrome: Genetics and Future Perspective.. Pediatr Cardiol 40(7):1419-1430 PMID: 31440766
- 7. Wei X et al.. 2026. Physiology, Cardiac Repolarization Dispersion and Reserve.. PMID: 30725879
- 8. Osadchii OE. 2017. Role of abnormal repolarization in the mechanism of cardiac arrhythmia.. Acta Physiol (Oxf) 220 Suppl 712:1-71 PMID: 28707396
